Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UPM Raflatac accelerates its growth in Graphics by acquiring Grafityp

(UPM Raflatac, Helsinki, 23 July 2024 at 10:00 EEST) – UPM Raflatac has acquired Grafityp, a Belgian-based company to further accelerate its growth in graphics solutions. Merging UPM Raflatac’s existing Graphics business with Grafityp will strengthen UPM Raflatac’s overall competitive positioning in this attractive product segment, expand its portfolio and give access to high-value new technologies. Both parties have agreed not to disclose the purchase price or other transaction details.   Grafityp is a well-established company with more than 50 years of history and a pioneer in

K-Fast Holding AB (publ): Interim report January-June 2024

*K-Fastigheter’s subsidiary K-Prefab has signed its single largest order to date with a value of SEK 200 million. The agreement with Noccon with Wallenstam as end customer, is for a complete framework contract for apartments, premises, and parking garages in Årstaberg in Stockholm. Improved order situation in K-Prefab where the remaining order value amounts to SEK 1,150.2 million compared to SEK 522.7 million at the corresponding time last year.  *A transfer agreement regarding a Danish portfolio comprising 311 apartments has been signed with Viga Real Estate. Viga took over the portfolio

Diamyd Medical receives positive feedback from FDA on potential Accelerated Approval for Diamyd® in Type 1 Diabetes

Diamyd Medical received encouraging feedback from the U.S. Food and Drug Administration (FDA) regarding an Accelerated Approval pathway for its immunotherapy, Diamyd[®,] for treating patients with Stage 3 Type 1 Diabetes carrying the genotype HLA DR3-DQ2.In a recent in-person Type C Meeting the FDA acknowledged that C-peptide could be used by Diamyd Medical as a surrogate endpoint reasonably likely to predict the clinical benefit of preservation of endogenous insulin production. As such, Accelerated Approval could be sought based on a demonstration of significant treatment-related benefits

Flowscape wins orders with top brand in the fashion industry

One of the world's most famous fashion companies chooses Flowscape's solution in Australia. The customer wants to create an efficient office where the staff can decide to sit with their teams while the spaces are used optimally. The order value in the first year is EUR 14,260 (SEK 166,000) and thereafter EUR 8,220 (SEK 95,000) annually."We are incredibly happy that yet another global top company chooses Flowscape's solution to manage and analyse their workplaces and meeting rooms. This customer has one of the world's most well-known brands, within the fashion industry, and thus has very

British compressed air distributor located in Kent, UK, has become part of Atlas Copco Group

Nacka, Sweden, July 23, 2024: Kingsdown Compressed Air Systems Limited (“Kingsdown”), a distributor of compressed air and other equipment in the UK has become part of Atlas Copco Group.Kingsdown was founded in 1996 and is located in Wrotham, Kent, England. The company has a wide range of customers in all types of manufacturing industries, such as food & drinks, textiles, printing, and advanced manufacturing. “Kingsdown is well renowned with strong sales and service and has an impressive market presence in its region”, said Philippe Ernens, Business Area President Compressor Technique. “

The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K

The board of Cyxone AB (publ), corporate no. 559020-5471, ("Cyxone" or the "Company") has today resolved on a new issue of shares with preferential rights for the Company's existing shareholders for a total of approximately SEK 23 million before deductions for transaction costs (the "Rights Issue"). The decision has been made with the support of authorization from the annual general meeting in 2024. The purpose of the capital acquisition is primarily to finance development programs with exploratory studies with the drug candidate rabeximod for patients who do not respond well to TNFa

UPM Half-Year Financial Report 2024: Comparable EBIT increased by 60% in Q2, UPM Paso de los Toros reached full capacity

UPM-Kymmene Corporation Stock Exchange Release (Half-Year Financial Report) 23 July 2024 at 09:30 EEST UPM Half-Year Financial Report 2024:Comparable EBIT increased by 60% in Q2, UPM Paso de los Toros reached full capacity   Q2 2024 highlights · Sales totalled EUR 2,546 million (2,558 million in Q2 2023) · Comparable EBIT increased by 60% to EUR 182 million, 7.2% of sales (114 million, 4.5%) · Operating cash flow was EUR 204 million (459 million) · Moderate recovery in many product markets · UPM Paso de los Toros pulp mill reached nominal capacity before its

Repurchases of shares week 29, 2024

Between 15 July and 18 July 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 94,653 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 24 April 2024. The repurchase program, which runs between 29 April 2024 and 18 July 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated Regulation (EU) No

Akobo Minerals reports successful commissioning of Segele gold processing plant

OSLO, 23 July 2024: Akobo Minerals AB  (Euronext and Frankfurt: AKOBO) (OTCQX:AKOBF). Akobo Minerals, a leading gold exploration and mining company based in Scandinavia with operations in Ethiopia, is pleased to announce that the Segele processing plant is now operational. This milestone represents a significant advancement for the company’s operations in Ethiopia. [Et bilde som inneholder himmel, utendørs, vann, svømmebasseng Automatisk generert beskrivelse]

BioGaia AB: Interim Management Statement January – June 2024

SECOND QUARTER 2024(For balance sheet items, figures in parentheses refer to year-end 2023 figures. For income statement and cash flow items, they refer to the same period last year). Net sales amounted to SEK 384.1 million (315.2), an increase of SEK 68.9 million, or 22% (excluding foreign exchange effects, 21%). Net sales in the Pediatrics segment amounted to SEK 304.8 million (231.7), an increase of 32% (excluding foreign exchange effects an increase of 30%). Net sales in the Adult Health segment amounted to SEK 78.2 million (83.0), a decrease of 6% (excluding foreign exchange

Long-term treatment data for lecanemab to be presented at AAIC 2024

Stockholm, July 23, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) today announced that its partner Eisai will present the latest findings on lecanemab (generic name, brand name Leqembi®) at the Alzheimer’s Association International Conference (AAIC) 2024. The conference will be held in Philadelphia and virtually from July 28 to August 1, 2024. Data presented will include three-year efficacy and safety data, as well as data supporting the importance of continued treatment of Alzheimer’s disease. In addition, BioArctic will present a poster on the Nordic Healthcare system’s readiness to

Nordnet publishes its second quarter 2024 interim report

Nordnet today publishes its interim report for the second quarter January-June 2024. The full report is available at www.nordnetab.com- Nordnet can glance back on strong quarter with a continued stable inflow of savings and new customers, a high pace of product development and a record-breaking financial performance. Income increased by 20 percent compared with same period last the year to a new record level of SEK 1,289 million. Overall, we can report an operating profit of SEK 904 million for the period April-June – an increase of 24 percent compared with corresponding period in the

Tietoevry's Interim Report 2/2024: Steady performance in a mixed market

Tietoevry Corporation HALF-YEAR REPORT      23 July 2024, 9.00 a.m. (EEST)   · Organic growth of 1% driven by software businesses · Improved profitability of 11% supported by Tietoevry Tech Services · Strong customer wins and order intake – book-to-bill 1.3 · Strategic review of Tietoevry Tech Services progressing – active sales process ongoing   The full interim report with tables is available at the end of this release.     4–6/2024 4–6/2023 1–6/2024 1–6/2023Revenue, EUR million  715.0  695.2  1 448.9  1 439.5

Kesko’s financial reporting and Annual General Meeting in 2025

The 2025 calendar for Kesko Group's financial reporting concerning the years 2024 and 2025 is as follows: · Year 2024 financial statements release on 5 February 2025 · Year 2024 Annual Report (incl. the financial statements and the Report by the Board of Directors) will be published in week 9 at the latest  · Year 2025 3-month interim report on 29 April 2025 · Year 2024 6-month half-year financial report on 22 July 2025 · Year 2024 9-month interim report on 30 October 2025 Kesko Corporation's Annual General Meeting is planned for 24.3.2025. The meeting will be convened

GiG further extends UK growth with Betzone partnership for iGaming platform with enhanced compliance solution

Gaming Innovation Group Inc. (GiG) has extended its footprint in the UK with the announcement of a long term agreement to power the Betzone brand with its revolutionary iGaming platform, CoreX, and powerful workflow automation tools LogicX and DataX, as GiG continues the execution of its strategic growth plans for the region. The second UK deal to be announced for GiG in as many weeks, the agreement stands as further evidence of GiG’s ability to attract ambitious new partners looking for sustainable growth in complex regulated markets, leveraging the competitive advantage its suite of

Skanska upgrades railway station in Jihlava, Czech Republic, for CZK 1.3 billion, about SEK 570M

Skanska has signed a contract with The Railway Administration of the Czech Republic for the modernization of Jihlava-City railway station. The contract is worth CZK 1.3 billion, about SEK 570M, which will be included in the order bookings for Europe for the third quarter 2024.The project will include modern track configuration with 5.6 kilometers of new tracks, installing 15 new switches and new station security systems.  Skanska will also build two barrier-free platforms, and a new station building. Once completed, the modernization will bring increased reliability and safety in the

HANZA interim report January-June 2024

HANZA reports a second quarter 2024 that continues to be characterized by the recession. However, new sales are good, and the company has implemented a cost-saving program that starts to improve the earnings at the end of the period. Furthermore, HANZA has executed a number of activities in accordance with the strategy HANZA 2025 during the second quarter and the business is also supported by a continued strong cashflow. Overall, the company sees a positive development of both sales and margins going forward.Second quarter 2024 · Net sales increased by 14% to SEK 1,221 million (1,068).

Alfa Laval AB (publ) Interim report April 1 – June 30, 2024

Highlights · Order intake was SEK 18.9 (18.4) billion, an organic increase of 4 percent. · Net sales was SEK 17.5 (15.9) billion, an organic increase of 11 percent. · Adjusted EBITA increased by 23 percent to SEK 2.9 (2.4) billion, corresponding to a margin of 16.7 (15.0) percent. · Strong cash flow from operating activities of SEK 2.6 (1.3) billion. · Earnings per share of SEK 4.08 (3.63).Summary Second quarter Order intake increased by 4 percent* to SEK 18,916 (18,405) million.Net sales increased by 11 percent* to SEK 17,530 (15,880) million. Adjusted EBITA**:

Halton Invests Over 3 Million Euros to Establish New Manufacturing Facility in Anderson, South Carolina, USA

Lahti, Finland, July 23, 2024 – Halton Group, a family-owned company specializing in indoor air products and solutions, announces an investment in a new manufacturing facility in Anderson, South Carolina, USA. This new facility will serve Halton’s clients in the Marine, Energy, and Infrastructure sectors across the Americas, with production expected to start in the autumn of 2024.According to Sami Piirainen, Halton Marine’s Managing Director, the decision to establish the Anderson facility reflects Halton’s commitment to serving customers both globally and locally. With over 30 years of

Embla Medical hf: Interim Report Q2 2024

· Delivering our highest ever quarterly sales amounting to USD 217 million · Organic growth of 6% for Q2 driven strong performance in Prosthetics & Neuro Orthotics and Patient Care · EBITDA was USD 47 million and EBITDA margin was 22% for Q2 · Medicare in the US has finalized a proposal that grants active K2 patients access to prosthetic knees · New exciting innovation launched in bionics with NAVii[®] by Össur and Icon[®] by College ParkAnnouncement no. 11/2024 Interim report Q2 2024 23 July 2024 Sveinn Sölvason, President and CEO, comments: “We delivered our

Sedana Medical AB’s Interim report January-June 2024

Enrolment of both US clinical trials completed, on track for first results in 2H.Second quarter 2024 · Net sales for the quarter totaled MSEK 41.1 (37.3), equivalent to an increase of 10% compared to the same quarter 2023. At constant exchange rates, sales increased by 10%. · Gross profit was MSEK 29.0 (26.6) equivalent to a margin of 71% (71%). · Earnings before interest, taxes, depreciation and amortization (EBITDA) totaled MSEK -13.9 (-10.7), equivalent to an EBITDA margin of -34% (-29%). EBITDA ex-US for the quarter was MSEK -10.8 (-10.2) corresponding to a margin of -26% (-

Kesko half-year financial report 1.1.-30.6.2024: Good performance in a weak market

FINANCIAL PERFORMANCE IN BRIEF: 4-6/2024 · Group net sales in April-June totalled €3,093.4 million (€3,104.7 million); reported net sales were down by 0.4%, and comparable net sales by 4.1% · Comparable operating profit totalled €178.3 million (€207.6 million) · Operating profit totalled €159.2 million (€206.3 million) · Cash flow from operating activities totalled €309.0 million (€285.2 million) · Comparable earnings per share €0.30 (€0.38); reported earnings per share €0.26 (€0.38) 1-6/2024 · Group net sales in January-June totalled €5,852.9 million (€5,932.7

Vår Energi reports strong operational and financial performance in the second quarter and first half of 2024

Sandnes, Norway, 23 July 2024: Vår Energi ASA (OSE: VAR) reports strong operational performance and financial results in line or better than guidance. The Company is on track to deliver on the 2025 growth target and unlock future value.  Strong operational performance · Production of 293 kboepd in first half in the upper end of guidance range for the period · Good production efficiency on operated fields · Maintenance program successfully executed in the quarter Good financial performance · Total income in the quarter was USD 1 940 million, a decrease of USD 16 million

There are no items matching the current filter
There are no more items matching the current filter
Back to top